Hypoallergenic wheat ‰our produced by modiˆcation with cellulase and actinase showed inhibitory activity against ovalbumin permeation in an in vitro model by using the Caco-2 cell monolayer. The activity was found in the cellulase preparation used for producing the ‰our. An active compound was isolated by HPLC and identied as Trp-Ser-Asn-Ser-Gly-Asn-Phe-Val-Gly-Gly-Lys by 1 H-NMR data and Edman degradation. The undecapeptide, some oligopeptides with the N-terminal sequences and Trp ethyl ester showed activity at 10 -7 M, acetyl Trp being active at 10 -2 M. These data suggest that the Trp residue without a free carboxyl group would be required for the inhibitory activity of ovalbumin absorption through the intestinal tract.
Allergic diseases are the most common of all immunologically mediated conditions and are increasing in prevalence in most countries of the developed world. Food allergy has been thought to involve an excessive immune reaction against allergens absorbed from the intestinal tract. 1) After ingesting a speciˆc food antigen, a sensitized individual may experience gastrointestinal symptoms such as diarrhea and nausea, and extraintestinal symptoms can occur in the skin and airways.
2) The intestinal epithelium theoretically acts as a barrier restricting the permeation of macromolecules. However, a small part (10 "3 to 10 "4 ) of dietary proteins can cross the epithelium to access and activate eŠector cells, resulting in food allergy. 3) Yu et al. 4) have reported that sensitization to an antigen enhanced CD23 expression in intestinal epithelial cells, with a resulting increase in the transport kinetics of the antigen. Moreover, it has been reported that antigen permeability through the intestinal tract was enhanced in allergic patients 5, 6 ) and Crohn's disease patients. 7) In the light of these facts, it is conceivable that enhancing the barrier function of the intestinal epithelium would help to prevent food allergy.
Our group has been undertaking studies on wheat allergens and has proposed a procedure for producing hypoallergenic wheat ‰our by enzymatic modiˆ-cation. 8) This procedure involves the digestion of wheat ‰our with cellulase and actinase and successfully reduced the allergenicity. 8) Since hypoallergenic ‰our has poor functionality for food processing and needs to be processed into easy-to-eat foods, we have proposed methods to prepare some food items, including noodles and bread. 8, 9) The majority of wheatallergic patients did not show allergic symptoms after a hypoallergenic ‰our intake in our clinical test (unpublished data). Moreover, we have recently reported that the hypoallergenic ‰our actively suppressed the allergic reactions in an animal model. 10) We hypothesized that some components in hypoallergenic wheat ‰our showed inhibitory activity against allergen absorption, and that the inhibitor(s) contributed to the allergy-suppressive eŠect of the hypoallergenic wheat ‰our. To isolate the allergen absorption inhibitor(s), we selected a monolayer of Caco-2, the human colon carcinoma cell line, as an intestinal model. This monolayer exhibits microvilli and polarized morphology when grown on a permeableˆlter.
11) Ovalbumin (OVA), the major allergen of egg white, was used as an allergen model. This study demonstrates that an undecapeptide in the hypoallergenic wheat ‰our strongly inhibited OVA permeation through the Caco-2 monolayer, and that the Trp-residue with the bound carboxyl group of the peptide was important for its inhibitory activity. Trp-Ser-Asn-Ser-Gly-Asn-Phe-Val-Gly-Gly-Lys, Trp-Ser-Asn-Ser-Gly and Trp-Gly were obtained from Peptide Institute (Osaka, Japan). Trp-Ser-Asn and Trp-Ser were synthesized by the solid-phase method with a peptide synthesizer (Shimadzu PSSM-8) and then puriˆed by HPLC, the conditions being the same as those in theˆrst HPLC run described later, except for the linear gradient of 10-50z acetonitrile in 0.1z tri‰uoroacetic acid (TFA). The retention times of Trp-Ser-Asn and Trp-Ser were 10.8 and 5.9 min, respectively. Other reagents used were all of normal reagent grade.
Materials and Methods

Materials
Preparation of the hypoallergenic wheat ‰our. Soft ‰our was successively treated with cellulase at 509 C for 1 h and then with actinase at 409 C for 1 h at pH 7 by our reported method.
8)
Preparation of aqueous methanol-soluble fractions from the hypoallergenic ‰our and its materials. Each sample (1 g) of hypoallergenic ‰our, intact ‰our, cellulase and actinase was extracted with 50z methanol (10 ml), and the extract was dried under vacuum. The residue was submitted to activity measurements.
Extraction and pretreatment of an active fraction. Cellulase (50 g) was mixed with 50z methanol (500 ml) and then centrifuged at 5000×g for 20 min to obtain a supernatant. The supernatant was evaporated under vacuum. The residue was dissolved in 0.1z TFA (500 ml), and an aliquot (25 ml) of the solution was treated in an octadecylsilyl (ODS) column (Waters, Sep-Pak C18). The column was washed with the same solvent (10 ml) and then eluted with 80z methanol in 0.1z TFA.
Isolation of the active compound. The fraction adsorbed by ODS and eluted by 80z methanol was separated by theˆrst HPLC run in a reversed phase column (Shodex RSpak RP18-415, 4.6×150 mm). Linear gradient elution was used starting with 40z methanol in 0.1z TFA and ending with 60z methanol in 0.1z TFA at a ‰ow rate of 1 ml W min at 209 C. Detection was at the wavelength of 220 nm. The eluates collected near and at each peak were dried and then submitted to activity measurements. The active peak obtained by theˆrst HPLC run was separated by the second HPLC run in the reversedphase column (Shodex RSpak ODP-50-4D, 4.6× 150 mm) with elution by 17.5z acetonitrile in 0.1z TFA (isogratic), the other conditions being the same as those used in theˆrst run. The active peak obtained by the second HPLC run was separated by a third run in the reversed-phase column (Shodex RSpak RP18-415, 4.6×150 mm) by linear gradient elution with 40-50z methanol in 10 mM ammonium acetate, the other conditions being the same as those used in theˆrst run. The active peak obtained by the third HPLC run was desalted in the same manner in the second HPLC run.
Identiˆcation of the active compound. H-NMR and 2D HH COSY spectra were recorded by a Bruker AMX500 spectrometer operated at 500 MHz and 249 C. Chemical shifts were found relative to the residual methyl proton signal (d3.30 ppm) of methanol-d4. The active fraction was separately determined for its N-terminal amino acid sequence by auto-Edman degradation with an amino acid sequencing system (Hewlet Packard G1005A). The amino acid sequence similarity of the active compound and other proteins was checked by a computer program (Fast Homology Search CDS, GenBank).
Cell culture. The Caco-2 cells used in this study were between 30 and 50 passages. The growth medium contained DMEM with 20z FCS, 1z nonessential amino acids and antibiotics (100 IU W ml of penicillin, 100 mg W ml of streptomycin and 50 mg W ml of gentamycin). The cells were maintained in a humidiˆed atmosphere containing 5z CO 2 at 379 C and were normally grown to con‰uence in 75-cm 2 tissueculture ‰asks. The cells were then seeded into transwell cell culture chambers coated with type-I collagen at a density of 2×10 5 cells W cm 2 . Each well was placed in a cluster plate with the external medium (basolateral side, 1.5 ml) and the internal medium (apical side, 0.5 ml). The cells were fed with fresh media every 24 h. The transepithelial electrical resistance (TEER) of the cell monolayer reached more than 300 V W cm 2 after 14-21 days of culture, and this layer was used for the activity measurements. TEER was measured with a Millicell ERS instrument with Ag W AgCl electrodes (Nihon Milli- The concentration of each extract was set at 1 mg W ml. Data bars represent the mean±s.e. The s.e. of the control (without any of the extracts) was ±8. Inhibitory activity is expressed as ( Pc-Ps) W Pc×100 (z), where Pc and Ps are permeated OVA in the absence and presence of the sample, respectively. pore, Tokyo, Japan).
Measurement of inhibitory activity against OVA permeation. One day before the activity measurements, the cells were cultured in DMEM with or without (control) the test sample. The cells were then washed twice with Hanks' balanced salt solution (HBSS) and incubated for 30 min in the external medium (1.5 ml of HBSS containing a test sample) and internal medium (0.5 ml of HBSS containing both OVA (0.5 mg) and the test sample). In the case of the undecapeptide, the peptide was dissolved in the internal medium alone, or in both the internal and external media. At the end of the incubation period, the external medium was taken, and permeated OVA was determined by competitive ELISA. Microtiter plates were coated with the rabbit anti-OVA antiserum (100 ml, 1:5,000 dilution, Nordic Immunology, The Netherlands) and left overnight at 49 C. Unoccupied sites in the wells were saturated by incubating with 2z bovine serum albumin (BSA, 200 ml) at 379 C for 1 h . A mixture (100 ml) of a given concentration of digoxigenin (DIG)-labeled OVA and the external medium from the Caco-2 culture was incubated in the well at 379 C for 1.5 h. This was followed by the addition of peroxidase-conjugated anti-DIG (Boehringer Mannheim Co., Germany) and then o-phenylenediamine (Wako Pure Chemical Ind., Japan). The wells were washed between each addition with 0.05z Tween-20 in PBS. After the reaction, the absorbance at 490 nm was read by a microplate reader (Bio-Rad model 450). The inhibitory activity for OVA permeation is expressed as ( Pc-Ps) W Pc×100 (z), where Pc and Ps are permeated OVA in the absence and presence of the sample, respectively.
Results and Discussion
The hypoallergenic wheat ‰our did not develop any allergic symptoms, but consumption of the ‰our sometimes suppressed the allergic reactions in clinical and animal tests. 10) We thus hypothesized that this eŠect might have been, at least in part, a result of the hypoallergenic ‰our possessing some inhibitory functions for allergen absorption. Caco-2 is a human colon carcinoma cell line which exhibits various enterocytic characteristics such as the intercellular tight junction, nutrient transporters and brush-border enzymes. We used the monolayer of Caco-2 cells as a model of the small intestinal tract, and OVA was used as a typical allergen.
The 50z methanol-soluble fraction from the hypoallergenic ‰our was assayed for its inhibitory activity toward OVA permeation at a concentration of 1 mg W ml, being judged to be active. The fraction mainly consisted of oligosaccharides and peptides derived from the enzymatic process used in the hypoallergenic ‰our production.
8) The hypoallergenic ‰our also contained enzyme preparations of cellulase and actinase as minor components. To isolate the active compound(s) weˆrst assayed the activity of the 50z methanol extracts from intact ‰our and from the two enzyme preparations. Figure 1 shows that the cellulase preparation was active.
The extract from the cellulase preparation was pretreated with ODS (Sep-Pak) and then chromatographed by theˆrst HPLC run. One peak (Fig. 2-A, asterisked) was active. The active peak was separated by the second HPLC run to obtain an active peak (asterisked in Fig. 2-B) . This active peak was submitted to the third HPLC run, eluting with a methanol-ammonium acetate system. The active peak (Fig. 2-C, asterisked) was desalted to obtain a white powder (about 0.1 mg from 50 g of the cellulase preparation).
The 1 H-NMR spectrum of the active compound indicated its peptide nature. Unfortunately, spectral complication and the small sample amount made it di‹cult to unambiguously assign each amino acid residue. 2D HH COSY data partly clariˆed the proton networks. Four coupled aromatic protons at d 7.67-7.06-7.14-7.38 and a multi-proton broad singlet at A, ODS-adsorbed-80z methanol-eluted fraction of the cellulase preparation. B, Active peak of theˆrst HPLC run (asterisked in Fig. 2-A) . C, Active peak of the second HPLC run (asterisked in Fig. 2-B) . In each chromatogram, an asterisked peak shows the inhibitory activity against OVA permeation, the vertical axis being drawn to an arbitrary scale. Filled column: The undecapeptide was added to both the external and internal media. Unˆlled column: The undecapeptide was added only to the internal medium. In both cases, no activity was found at 10 "8 M. Data bars represent the mean±s.e. The s.e. of the control (without the undecapeptide) was ±12. * Signiˆcantly diŠerent (Pº0.05) from the control sample.
suggest two residues of Ser as well as d 4.62-2.62 W 2.71 for Asx.
The compound was then submitted to an amino acid sequence determination. The determined structure was Trp-Ser-Asn-Ser-Gly-Asn-Phe-Val-Gly-Gly. The amino acid sequence similarity shows that the active compound agreed with the 39-48th amino acid sequence of Tricoderma endo-1,4-b-xylanase (EC 3.2.1.8). The C-terminal amino acid residue of the compound should be Lys according to the NMR data. Summarizing the analytical data, we identiˆed the compound as the undecapeptide of Trp-Ser-AsnSer-Gly-Asn-Phe-Val-Gly-Gly-Lys.
The activity-concentration relationship was measured by using a synthetic peptide. Figure 3 shows that the undecapeptide was active at concentrations between 10 "5 and 10 "7 M, when it existed only in the internal medium or both internally and externally. The data suggest that the ingested peptide would be eŠec-tive if it were transported to the small intestine. We next examined which amino acid residue(s) of the undecapeptide were essential for the activity. A halfsized peptide of Trp-Ser-Asn-Ser-Gly and smaller peptides of Trp-Ser-Asn and Trp-Ser were all active at 10 "7 M (Fig. 4) . Trp-Gly was also active at the same molar concentration (Fig. 4) , suggesting that the Trp residue would have contributed to the activity development. Figure 5 shows that the Trp ethyl ester and acetyl Trp were active at molar concentrations of 10 "7 and 10 "2 , respectively. The data also suggest that the Trp residue without a free carboxyl group would be favorable for the inhibitory activity. Summarizing the data obtained in this work, we conclude that the Trp residue with the bound carboxyl group is required for the activity inhibiting OVA absorption. The hypoallergenic ‰our probably contains a su‹cient concentration of the active undecapeptide and its fragments, and the peptides would function as an inhibitors of OVA permeation.
The active undecapeptide and its fragments possibly contribute to the allergy-suppressive eŠects of the hypoallergenic ‰our. We also expect that the hypoallergenic ‰our would function as a preventive foodstuŠ against allergies induced by other allergens including egg and milk.
